Financhill
Back

Affimed NV 10K Form

Sell
45

AFMD
Affimed NV

Last Price:
3.26
Seasonality Move:
2.72%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AFMD News And Ratings

See the #1 stock for the next 7 days that we like better than AFMD

AFMD Financial Statistics

Sales & Book Value

Annual Sales: $8.96M
Cash Flow: $-17.57M
Price / Cash Flow: 0
Annual Sales: $1.96
Price / Book: 1.67

Profitability

EPS (TTM): -5.70590
Net Income (TTM): $-85.74M
Gross Margin: $0
Return on Equity: -131.11%
Return on Assets: -83.33%

Affimed NV Earnings Forecast

Key Affimed NV Financial Ratios

  • The Gross Profit Margin over the past 4 years for AFMD is 0.00%.
  • The Selling, General & Administrative Expenses for AFMD have been equal to 298.19% of Gross Profit Margin.
  • The Research & Development expenses have been 1,147.53% of Revenue.
  • The Interest Expense is -1.70% of Operating Income.
  • The Net Earning history of AFMD is -1,280.22% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 4 years.

Affimed NV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: AFMD
Website: affimed.com

Debt

Debt-to-Equity Ratio: 0.33
Current Ratio: 2.71
Quick Ratio: 2.46

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AFMD Technical Analysis vs Fundamental Analysis

Sell
45
Affimed NV (AFMD) is a Sell

Is Affimed NV a Buy or a Sell?

  • Affimed NV stock is rated a Sell
    The current Affimed NV [AFMD] share price is $3.27. The Score for AFMD is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.